The review panel shall examine the following areas relating to fungal contamination in indoor environments:
(a) Medical and public health.
(b) Evaluation and monitoring.
(c) Remediation and prevention.
(d) Educational materials.
(e) Hazard communication.
(f) Any other area identified by the review panel.
(Added by Stats. 2001, Ch. 550, Sec. 2. Effective January 1, 2002.)